Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial
- PMID: 16215410
- DOI: 10.1097/01.ccm.0000183002.26587.ff
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial
Comment on
-
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment.Crit Care Med. 2005 Oct;33(10):2266-77. doi: 10.1097/01.ccm.0000181729.46010.83. Crit Care Med. 2005. PMID: 16215381 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical